11-117986470-G-A

Variant summary

Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate

The NM_001558.4(IL10RA):​c.3G>A​(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

IL10RA
NM_001558.4 start_lost

Scores

5
6
5

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 3.88
Variant links:
Genes affected
IL10RA (HGNC:5964): (interleukin 10 receptor subunit alpha) The protein encoded by this gene is a receptor for interleukin 10. This protein is structurally related to interferon receptors. It has been shown to mediate the immunosuppressive signal of interleukin 10, and thus inhibits the synthesis of proinflammatory cytokines. This receptor is reported to promote survival of progenitor myeloid cells through the insulin receptor substrate-2/PI 3-kinase/AKT pathway. Activation of this receptor leads to tyrosine phosphorylation of JAK1 and TYK2 kinases. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Jan 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 8 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 4 pathogenic variants. Next in-frame start position is after 150 codons. Genomic position: 117993321. Lost 0.258 part of the original CDS.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-117986470-G-A is Pathogenic according to our data. Variant chr11-117986470-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 3656591.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL10RANM_001558.4 linkc.3G>A p.Met1? start_lost Exon 1 of 7 ENST00000227752.8 NP_001549.2 Q13651
IL10RAXM_047426882.1 linkc.-337G>A 5_prime_UTR_variant Exon 1 of 7 XP_047282838.1
IL10RANR_026691.2 linkn.77G>A non_coding_transcript_exon_variant Exon 1 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL10RAENST00000227752.8 linkc.3G>A p.Met1? start_lost Exon 1 of 7 1 NM_001558.4 ENSP00000227752.4 Q13651

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1401602
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
691732
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inflammatory bowel disease 28 Pathogenic:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change affects the initiator methionine of the IL10RA mRNA. The next in-frame methionine is located at codon 150. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individuals with inflammatory bowel disease (PMID: 35366317, 36370291). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that disruption of the initiator codon affects IL10RA function (PMID: 36370291). This variant disrupts a region of the IL10RA protein in which other variant(s) (p.Arg117Cys) have been determined to be pathogenic (PMID: 24001973, 30212871). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.32
D
BayesDel_noAF
Pathogenic
0.22
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.17
T
Eigen
Uncertain
0.36
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.44
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Benign
-0.68
T
PROVEAN
Benign
-1.7
N
REVEL
Uncertain
0.40
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.089
T
Polyphen
0.99
D
Vest4
0.93
MutPred
0.89
Loss of disorder (P = 0.1673);
MVP
0.95
ClinPred
1.0
D
GERP RS
3.2
Varity_R
0.96
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-117857185; API